Top Markets
#1 Ontology Gas Ontology Gas +31.11%
#2 Verus Coin Verus Coin +22.50%
#3 Status Status +21.81%
#4 Bitway Bitway +15.86%
#5 ETHGas ETHGas +15.11%
#6 Geodnet Geodnet +14.89%
#7 The Black Bull The Black Bull +11.57%
#8 Derive Derive +11.47%
#9 Curve DAO Curve DAO +11.06%
#10 Fake World Assets Fake World Assets +10.89%
Coin of the day
Ontology Gas Ontology Gas
Setări
Limbă
ROMâNă
Monedă
USD
Temă
AlloVir, Inc. AlloVir, Inc.

AlloVir, Inc.

ALVR
Rang în acțiuni #25521
AlloVir, Inc. is a biotechnology company in the clinical stage, dedicated to... AlloVir, Inc. is a biotechnology company in the clinical stage, dedicated to researching and developing allogeneic, "off-the-shelf" multi-virus specific T-cell (VST) therapies. Its primary goal is to prevent and treat severe diseases caused by viral infections. The company's lead product, posoleucel, is an allogeneic, ready-to-use VST therapy designed to combat several significant viruses, including BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, human herpesvirus 6, and JC virus. Beyond this flagship candidate, AlloVir's pipeline features additional investigational treatments in various stages of development. These include ALVR106, which targets respiratory syncytial virus, influenza, parainfluenza virus, and human metapneumovirus; ALVR109, developed to address SARS-CoV-2 and COVID-19; ALVR107, for treating hepatitis B; and ALVR108. Established in 2013, the company was initially known as ViraCyte, Inc. before officially rebranding as AlloVir, Inc. in May 2019. Its headquarters are located in Waltham, Massachusetts.
Preț acțiune
$9.81
Ultima sincronizare: 2025-03-18
Capitalizare de piață
$48.68M
Schimbare (1 zi)
1.55%
Schimbare (1 an)
0.00%
Țară
US
Tranzacționează AlloVir, Inc. (ALVR)

Categorie

Healthcare
Raport P/B pentru AlloVir, Inc. (ALVR)
Raport P/B la data de August 2026 TTM: 1.68
Conform celor mai recente rapoarte financiare și prețului acțiunilor AlloVir, Inc., raportul P/B actual (TTM) este 1.68. La sfârșitul anului 2023, compania avea un P/B de 0.00.
Istoricul raportului P/B pentru AlloVir, Inc. din 2022 până în 2026
Raport P/B la sfârșitul fiecărui an
An Raport P/B Schimbă
2026 (TTM) 1.68 320.88%
2024 0.40 0.00%
2023 0.00 0.00%
2022 0.00 0.00%
Raport P/B pentru companii similare sau competitoare
Companie Raport P/B Diferență raport P/B Țara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 276.71%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 270.73%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 48.82%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 120.30%
US